Every day, AHA staff take to Capitol Hill to tell the hospital story, working to educate Congress on key issues and the field’s concerns. We also advocate with federal regulators, provide expert testimony, and highlight the impact proposed changes could have and suggest alternative solutions. Below are the most recent statements the AHA has submitted for the record for congressional hearings or agency panels.


Jul 10, 2018
On behalf of our nearly 5,000 member hospitals, health systems and other health care organizations, including more than 1,900 hospitals that participate in the 340B drug savings program, and our cl
Jun 27, 2018
AHA statement before the Senate Committee on Health, Education, Labor and Pensions: Hearing on How to Reduce Health Care Costs: Understanding the Cost of Health Care in America”
Jun 26, 2018
AHA statement before the Senate Finance Committee on Prescription Drug Affordability and Innovation: Addressing Challenges in Today’s Market.
Jun 19, 2018
AHA Statement before the Senate Committee on Health, Education, Labor and Pensions regarding “Effective Administration of the 340B Drug Pricing Program.”
Jun 6, 2018
AHA Statement to the Committee on Ways and Means for “Hearing on Lowering Costs and Expanding Access to Health Care through Consumer-Directed Health Plans.”
May 15, 2018
AHA Statement before the Senate Committee on Health, Education, Labor and Pensions: Examining Oversight Reports on the 340B Drug Pricing Program
May 8, 2018
AHA expresses strong support for legislation that would allow responsible sharing of patient substance use disorder (SUD) treatment information and prevent inappropriate
Apr 26, 2018
AHA submit statement before the House Ways and Means Subcommittee on Health.regarding innovative practices and technology in health care. 
Apr 9, 2018
AHA statement before the House Homeland Security Committee on emergency preparedness and lessons learned from Hurricane Harvey.